Transforming GSM Care: How Evidence, Experts, and Advocacy Changed the Label - Episode 86

AUA Leadership and Business · Dec 11, 2025 · 26m

Transforming GSM Care: How Evidence, Experts, and Advocacy Changed the Label

Host: Rachel Rubin, MD

Guest: Una Lee, MD

In November 2025, the FDA removed the black box warning from estrogen therapies, a significant victory for the AUA and its members, who have long advocated for this change. In this special release brought to you by AUA's Public Policy and Advocacy Team, @drrachelrubin and @dr_unalee take you inside the movement as they unpack the origins of the warning, the modern evidence that contradicts it, the impact on GSM care, and the powerful role urology played in driving this…